The Lingerfelt Companies has started the third phase of BioTech 8, a six-story tower within the 34-acre Virginia BioTechnology Research Park in Richmond, US.
The facility is an expansion for Health Diagnostic Laboratories (HDL), and on completion will increase total development at the park to more than 1.25 million ft².
The project will complete the $100m, 276,000ft² three-building headquarter complex for HDL, which includes a four-storey, 485-space parking deck.
Lingerfelt Companies principal Ryan Lingerfelt said the company will assist HDL in their expansion by developing all three of their buildings within the park.
"Since partnering with HDL in 2009, development has been fast paced with the third phase six-story tower scheduled for completion spring 2014," Lingerfelt said.
Earlier in April 2013, construction started on the $25m, phase two expansion of HDL’s 283,000ft² complex, which will house 400 additional employees after completion.
Phase one of HDL’s expansion was announced in November 2011 and saw the former BioTech Three building at the corner of East Jackson and North Fifth streets demolished.
The 112,000ft², six-storey complex under the first phase was added to HDL’s existing 76,000ft², three-storey building.
Phase two will be built at the corner of East Jackson and North Fifth streets and bordered to the south-east by Navy Hill Drive.
Upon its scheduled completion in April 2014, phase two will create 95,000ft² additional office space and wet laboratory space.
Features of the new headquarters include a rooftop park and green space, a gym, and the building’s atrium will include spiral slides linking the sixth, fifth, and fourth floors.
Image: BioTech Complex for Health Diagnostic Laboratory. Photo: Courtesy of McKinney & Company/PRNewswire.